CRIS Curis, Inc. Common Stock

Data is currently not available
CRIS
Data is currently not available
Access your previously viewed quotes
Your previously viewed symbols will appear here as you browse the site.
Previously Viewed
  • Data is currently not available
Quotes and Chart Key Data News Options Profile Filings - Ownership

CRIS

See real-time trades
SELECT THE TIMEFRAME :
Data is currently not available
Previous
Close  
See Pre-Market Trading See After-Hours Trading

Links for Quotes and Charts

Summary Data

Data is currently not available

Links for Key Data

Earnings Per Share

Estimated Reported
Data is currently not available
Estimated EPS 1.00
Reported EPS: 1.00
SEE ALL REVENUE AND Earnings Per Share

Dividend History

  • CRIS Ex-Dividend Date  
  • CRIS Dividend Yield  %
  • CRIS Annual Dividend $ 
  • CRIS Payout Ratio  %
Data is currently not available
 
   
See Full Dividend History

Short Interest

Data is currently not available
 
   
See Full Short Interest History

News Quick Links

Published
Dec 3, 2019
Markets

Curis To Present At Piper Jaffray Conference; Webcast At 11:30 AM ET

Published
Dec 3, 2019
Published
Sep 12, 2019
Markets

Curis Promotes Bill Steinkrauss As CFO - Quick Facts

Published
Sep 12, 2019
Published
Aug 6, 2019
Markets

EARNINGS SUMMARY: Details of Curis Inc Q2 Earnings Report

Published
Aug 6, 2019
Published
May 14, 2019

EARNINGS SUMMARY: Details of Curis Inc Q1 Earnings Report

Published
May 14, 2019
See More
See All News

News

Published
4 days ago

Curis Provides First-Ever Demonstration that Targeting IRAK4 in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma Results in Anti-Cancer Activity in Ongoing Phase 1 Study

Published
4 days ago
Published
4 days ago

Curis Announces Positive Safety, Tolerability and Pharmacokinetic Data in Ongoing Phase 1 Study of Fimepinostat in Combination with Venetoclax

Published
4 days ago
Published
Nov 26, 2019

Curis to Present at 31st Annual Piper Jaffray Healthcare Conference

Published
Nov 26, 2019
Published
Nov 6, 2019

Curis Abstracts for Fimepinostat and CA-4948 Accepted for Presentation at the 61st Annual Meeting of the American Society of Hematology

Published
Nov 6, 2019
Published
Nov 5, 2019

Curis Reports Third Quarter 2019 Financial Results

Published
Nov 5, 2019
Published
Oct 31, 2019

Curis to Release Third Quarter Financial Results and Hold Conference Call on November 5, 2019

Published
Oct 31, 2019
Published
Oct 4, 2019

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Published
Oct 4, 2019
Published
Aug 13, 2019

Curis Hires Industry Veterans to Lead Clinical Development and Regulatory Affairs

Published
Aug 13, 2019
Published
Aug 6, 2019

Curis Reports Second Quarter 2019 Financial Results

Published
Aug 6, 2019
Published
Jul 30, 2019

Curis to Release Second Quarter Financial Results and Hold Conference Call on August 6, 2019

Published
Jul 30, 2019
Published
Jul 5, 2019

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Published
Jul 5, 2019
Published
Jun 12, 2019

Curis Highlights Publication in Nature Cell Biology Identifying Cancer-Causing Form of IRAK4 in Patients with AML and MDS

Published
Jun 12, 2019
Published
May 14, 2019

Curis Reports First Quarter 2019 Financial Results

Published
May 14, 2019
Published
May 6, 2019

Curis Completes Mesothelioma Enrollment in CA-170 Study

Published
May 6, 2019
Published
Apr 10, 2019

Curis Regains Compliance with Nasdaq Continued Listing Requirements

Published
Apr 10, 2019
Published
Apr 5, 2019

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Published
Apr 5, 2019
See More
See All Press Releases

Published

Published

CRIS Analyst Ratings

Data is currently not available
Consensus  

 

See all analyst research

Forecasts

SELECT THE TIMEFRAME :
Data is currently not available
 
   

Option Chain

Data is currently not available
 
 
 
 
 
 
 
See full OPTION CHAIN history
Data is currently not available

Key Executives
Name Title
Address: Phone:
Fundamentals

Ownership and SEC Filings

Historical

Download Data
Data is currently not available
 
   
See Full Historical Data See Historical NOCP

Active stocks by Dollar Volume

AMZN

Data is currently not available
AAPL

Data is currently not available
TSLA

Data is currently not available
INTC

Data is currently not available

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this environment. Investors who anticipate trading during these times are strongly advised to use limit orders.

  • Real-time Data is provided using Nasdaq Last Sale Data